HAEHaemonetics Corp.
Company Overview
Name
52W High
52W Low
Market Cap
Dividend Yield
Price/earnings
P/E
Dividends
No dividend
Sentiment
Score
Very Bullish
97
Low
Neutral
High
0
50
100
Trade Volume
Score
Neutral
50
Low
Neutral
High
0
50
100
Income Statement
Total Revenue
Operating Revenue
Total Gross Profit
Total Operating Income
Net Income
EV to EBITDA
EV to Revenue
Price to Book value
Price to Earnings
Additional Data
Selling, General & Admin Expense
Research & Development Expense
Amortization Expense
Impairment Charge
Total Operating Expenses
Other Income / (Expense), net
Earnings History
- Estimated
- Reported, beat
- Reported, missed
Estimated EPS
Reported EPS
N/ACompany Overview
Name
52W High
52W Low
Market Cap
Dividend Yield
Price/earnings
P/E
Dividends
No dividend
Sentiment
Score
Very Bullish
97
Low
Neutral
High
0
50
100
Trade Volume
Score
Neutral
50
Low
Neutral
High
0
50
100
Income Statement
Total Revenue
Operating Revenue
Total Gross Profit
Total Operating Income
Net Income
EV to EBITDA
EV to Revenue
Price to Book value
Price to Earnings
Additional Data
Selling, General & Admin Expense
Research & Development Expense
Amortization Expense
Impairment Charge
Total Operating Expenses
Other Income / (Expense), net
Earnings History
- Estimated
- Reported, beat
- Reported, missed
Estimated EPS
Reported EPS
N/AUpcoming Earnings
Company Info
CEO
Christopher A. Simon
Location
Massachusetts, USA
Exchange
NYSE
Website
https://haemonetics.com
Summary
Haemonetics Corporation provides medical products and solutions.
Company Info
CEO
Christopher A. Simon
Location
Massachusetts, USA
Exchange
NYSE
Website
https://haemonetics.com
Summary
Haemonetics Corporation provides medical products and solutions.
Community Research
Research from investors like you
Be the first to share your analysis on HAE
Help fellow investors make informed decisions by sharing your research on fundamentals, catalysts, and outlook.
Symbol's posts
Haemonetics jumped because of increased plasma product usage
Haemonetics jumped because of increased plasma product usage
surger more than 17% after news that CSL Plasma had expanded the use of the company’s products. I know that this may not sound like much but think about it this way. In the broader marker, mostly the entire market shifts because of AI or oil. Pharma stocks are untouched and depend on the progress in healthcare. Should be a good idea to invest in some pharma stocks. What do you think?
No more topics to show
